Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-09 Sale |
2024-04-11 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
11,882 | $28.15 | $334,478 | 1,799,232 (Indirect) |
View |
| 2023-09-08 Sale |
2023-09-08 4:00 pm |
Surface Oncology Inc. | SURF | GRAYZEL DAVID S. Director |
2,945,453 | $0 | $0 | 0 (Indirect) |
View |
| 2021-07-02 Purchase |
2021-07-06 4:27 pm |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
535,714 | $14 | $7,499,996 | 3,106,032 (Indirect Direct) |
View |
| 2020-12-17 Sale(A) |
2020-12-21 3:35 pm |
Surface Oncology Inc. | SURF | GRAYZEL DAVID S. Director |
1,700,000 | $8.1 | $13,770,000 | 2,945,453 (Indirect) |
View |
| 2020-12-17 Sale |
2020-12-21 1:32 pm |
Surface Oncology Inc. | SURF | GRAYZEL DAVID S. Director |
1,700,000 | $18.1 | $30,770,000 | 2,945,453 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-24 Option Award |
2025-02-26 9:56 pm |
N/A 2034-03-24 |
Q32 Bio Inc. | QTTB | GRAYZEL DAVID S. Director |
52,526 | $0 | 52,526 (Direct) |
View |
| 2024-04-01 Option Award |
2024-08-14 4:05 pm |
N/A 2034-03-31 |
Q32 Bio Inc. | QTTB | GRAYZEL DAVID S. Director |
2,569 | $13.42 | 2,569 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 6:00 pm |
N/A 2034-06-04 |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2024-03-25 Option Award |
2024-03-27 5:39 pm |
N/A 2034-03-24 |
Q32 Bio Inc. | QTTB | GRAYZEL DAVID S. Director |
12,767 | $0 | 12,767 (Direct) |
View |
Ownership |
2024-03-27 5:24 pm |
N/A N/A |
Q32 Bio Inc. | QTTB | GRAYZEL DAVID S. Director |
0 | $0 | 2,092,106 (Indirect) |
View |
| 2024-01-02 Option Award |
2024-01-04 6:00 pm |
N/A 2034-01-01 |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
3,186 | $13.49 | 3,186 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 5:00 pm |
N/A 2033-01-02 |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
2,654 | $18.08 | 2,654 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 5:00 pm |
N/A 2032-06-20 |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 8:00 pm |
N/A 2032-06-08 |
Surface Oncology Inc. | SURF | GRAYZEL DAVID S. Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 5:15 pm |
N/A 2032-01-02 |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
7,317 | $6.56 | 7,317 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 4:27 pm |
N/A 2031-06-30 |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
2,153 | $11.15 | 3,106,032 (Direct) |
View |
| 2021-07-02 Conversion |
2021-07-06 4:27 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
10,544,919 | $0 | 3,106,032 (Indirect) |
View |
| 2021-06-29 Option Award |
2021-07-01 6:32 pm |
N/A 2031-06-28 |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
25,000 | $0 | 9,876,456 (Direct) |
View |
| 2021-02-01 Option Award |
2021-07-01 6:32 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
6,981,033 | $1.893 | 9,876,456 (Indirect) |
View |
Ownership |
2021-06-29 8:44 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
0 | $0 | 2,568,165 (Indirect) |
View |
| 2021-06-08 Option Award |
2021-06-10 4:30 pm |
N/A 2031-06-08 |
Surface Oncology Inc. | SURF | GRAYZEL DAVID S. Director |
17,700 | $0 | 17,700 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-12 08:00 am |
N/A 2030-06-10 |
Surface Oncology Inc. | SURF | GRAYZEL DAVID S. Director |
12,000 | $0 | 12,000 (Direct) |
View |